Article Versions Notes

Zhang D, Yong WH, Movassaghi M, Rodriguez FJ, Yang I, McKeever P, Qian J, Li JY, Mao Q, Newell KL, et al. Whole Exome Sequencing Identifies PHF14 Mutations in Neurocytoma and Predicts Responsivity to the PDGFR Inhibitor Sunitinib. Biomedicines. 2022; 10(11):2842. https://doi.org/10.3390/biomedicines10112842

Zhang, Dongyun, William H. Yong, Masoud Movassaghi, Fausto J. Rodriguez, Issac Yang, Paul McKeever, Jiang Qian, Jian Yi Li, Qinwen Mao, Kathy L. Newell, and et al. 2022. "Whole Exome Sequencing Identifies PHF14 Mutations in Neurocytoma and Predicts Responsivity to the PDGFR Inhibitor Sunitinib" Biomedicines 10, no. 11: 2842. https://doi.org/10.3390/biomedicines10112842

Zhang, D., Yong, W. H., Movassaghi, M., Rodriguez, F. J., Yang, I., McKeever, P., Qian, J., Li, J. Y., Mao, Q., Newell, K. L., Green, R. M., Welsh, C. T., & Heaney, A. P. (2022). Whole Exome Sequencing Identifies PHF14 Mutations in Neurocytoma and Predicts Responsivity to the PDGFR Inhibitor Sunitinib. Biomedicines, 10(11), 2842. https://doi.org/10.3390/biomedicines10112842